Credit rating of seven companies listed in the capital market was completed. This information is known from Dhaka Stock Exchange (DSE) sources.
The companies are: WATA Chemical, Ifad Autos, Fortune Suze, Tashrifa Industries, ITC, Orion Infusion, Orion Pharma.
WATA Chemical: The company is rated by Emerging Credit Rating Limited. The company is rated ‘BBB’ for long term and ‘ST-3’ for short term. This rating has been determined based on the information in the audited financial report for the financial year ended June 30, 2024.
Ifad Autos: The company’s rating has been determined by the Credit Rating Agency of Bangladesh Limited. The company is rated ‘AA3’ for long term and ‘ST-2’ for short term. The rating has been determined based on the audited financial report for the financial year ended June 30, 2024, the unaudited report as on October 31, 2024 and other information.
Fortune Suze: The company is rated by Credit Rating Information and Services Limited. The company is rated ‘BBB+’ for long term and ‘ST-4’ for short term. The rating is based on the audited financial report for the fiscal year ended June 30, 2024, the unaudited report as on September 30, 2024 and other information.
Tashrifa Industries: The company is rated by Credit Rating Information and Services Limited. The company is rated ‘AA-‘ for long term and ‘ST-3’ for short term. The rating has been determined based on the audited financial report for the financial year ended June 30, 2024, the unaudited report as on September 30, 2024 and other information.
ITC: The company has been rated by Credit Rating Agency of Bangladesh Limited. The company is rated ‘AA1’ for long term and ‘ST-1, ST-2’ for short term. The rating is based on the audited financial report for the financial year ended June 30, 2022-24, other information as on November 30, 2024.
Orion Infusion: The company has been rated by Credit Rating Agency of Bangladesh Limited. The company is rated ‘A3’ for long term and ‘ST-3’ for short term. The rating is based on the audited financial report for the financial year ended June 30, 2022-24, among other data as on September 30, 2024.
Orion Pharma: The company has been rated by Credit Rating Agency of Bangladesh Limited. The company is rated ‘AA3’ for long term and ‘ST-3’ for short term. The rating is based on the audited financial report for the financial year ended June 30, 2022-24, among other data as on September 30, 2024.
